Boston Bio Systems Reports Q2 Profit, Appoints New Auditors

BOSTON BIO SYSTEMS LTD. (BSE: BOSTONBIO) has announced its financial results for the second quarter and half-year ended September 30, 2025, alongside key appointments in its auditing team.

Financial Performance

The company reported an improvement in its financial performance for Q2 FY2025-26. Here's a breakdown of the key figures:

Particulars	Q2 FY2025-26	Q2 FY2024-25	H1 FY2025-26	H1 FY2024-25
Revenue	₹24.47 crore	Not available	₹42.52 crore	Not available
Profit After Tax	₹3.94 crore	(₹0.50 crore)	₹7.95 crore	(₹0.50 crore)
EPS (Basic & Diluted)	₹0.06	(₹0.01)	₹0.11	(₹0.01)

The company has shown a turnaround in its profitability compared to the same period last year. The revenue for Q2 FY2025-26 stood at ₹24.47 crore, while the half-yearly revenue reached ₹42.52 crore.

Appointment of Auditors

Boston Bio Systems has made two key appointments:

Secretarial Auditor: Mr. Shashank Kumar, Proprietor of M/s Shashank Kumar & Associates (FRN: S2018UP715500), has been appointed as the Secretarial Auditor for the Financial Year 2025-26.
Internal Auditor: Mr. Nishant Sharma, Proprietor of M/s Vyom Advisors, has been appointed as the Internal Auditor for the Financial Year 2025-26.

Management Commentary

No specific management comments were provided in the available data.

Looking Ahead

As Boston Bio Systems continues to navigate the business landscape, investors and stakeholders may observe how these financial improvements and new appointments contribute to the company's operations and corporate governance practices.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
0.0%	-0.26%	-3.74%	+6.04%	-63.01%	-63.01%

BOSTON BIO SYSTEMS LTD. has announced significant changes in its company secretarial position. The Board of Directors, in a meeting held on October 13, 2025, approved these changes based on the recommendation of the Nomination and Remuneration Committee.

Leadership Transition

The company has disclosed the following key changes:

Position	Outgoing	Incoming	Effective Date
Company Secretary and Compliance Officer	Ms. Mandeep Kaur	Ms. Nisha Yadav	October 13, 2025

Details of the Changes

Resignation of Ms. Mandeep Kaur

Ms. Mandeep Kaur has resigned from her position as Company Secretary.
Her resignation will take effect from the close of business hours on October 13, 2025.

Appointment of Ms. Nisha Yadav

Ms. Nisha Yadav has been appointed as the new Company Secretary and Compliance Officer.
Her appointment is effective from October 13, 2025.

Profile of the New Appointee

Ms. Nisha Yadav brings valuable experience to her new role:

Qualified Company Secretary from the Institute of Company Secretaries of India (ICSI).
Over 4 years of experience in dealing with matters related to the Companies Act, Listing Regulations, and allied laws.
No relationship with any Director of the Company.
Holds no shareholding in the company.

The company has made these changes in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Board meeting where these decisions were made started at 5:00 PM and concluded at 6:00 PM on October 13, 2025.

Boston Bio Systems Limited, with its registered office in Ahmedabad, Gujarat, continues to ensure proper corporate governance through these leadership transitions.